Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIOW) Equity Ratio (2021 - 2025)

Historic Equity Ratio for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to 0.93.

  • Cardio Diagnostics Holdings' Equity Ratio rose 1275.85% to 0.93 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.93, marking a year-over-year increase of 1275.85%. This contributed to the annual value of 0.9 for FY2024, which is 3582.3% up from last year.
  • According to the latest figures from Q3 2025, Cardio Diagnostics Holdings' Equity Ratio is 0.93, which was up 1275.85% from 0.94 recorded in Q2 2025.
  • Over the past 5 years, Cardio Diagnostics Holdings' Equity Ratio peaked at 0.97 during Q4 2021, and registered a low of 0.01 during Q1 2022.
  • Moreover, its 5-year median value for Equity Ratio was 0.7 (2022), whereas its average is 0.61.
  • Its Equity Ratio has fluctuated over the past 5 years, first crashed by 2898.32% in 2022, then surged by 327605.52% in 2023.
  • Cardio Diagnostics Holdings' Equity Ratio (Quarter) stood at 0.97 in 2021, then dropped by 28.98% to 0.69 in 2022, then fell by 3.69% to 0.66 in 2023, then soared by 35.82% to 0.9 in 2024, then rose by 3.01% to 0.93 in 2025.
  • Its Equity Ratio was 0.93 in Q3 2025, compared to 0.94 in Q2 2025 and 0.93 in Q1 2025.